Please check your internet connection and try again.
# Chymosin Forte
## Overview
Chymosin Forte is a proprietary enzymatic formulation primarily containing **chymotrypsin** and **trypsin**. These are proteolytic enzymes used for their anti-inflammatory, mucolytic, and fibrinolytic properties. It is often marketed as a systemic enzyme therapy to reduce post-traumatic or post-surgical edema. *Note: Regulatory status varies by region; it is considered a supplement or a non-standard therapeutic in many jurisdictions.*
## Primary Indications
* Reduction of inflammation and edema associated with trauma, surgery, or sports injuries.
* Adjunctive therapy for respiratory conditions involving thick, viscous mucus (mucolytic support).
## Adult Dosing
* **Standard Regimen:** 1 to 2 tablets (typically 100,000–300,000 USP units of proteolytic activity) administered orally 3 to 4 times daily.
* **Administration:** Must be taken on an empty stomach (at least 30–60 minutes before meals or 2 hours after meals) to prevent the enzymes from digesting dietary proteins rather than systemic targets.
## Pediatric Dosing
* **Safety/Efficacy:** Not well-established. Use is generally not recommended in children without specific oversight from a pediatric specialist. If prescribed, dosing is usually weight-based and determined by local institutional or practitioner-specific clinical protocols.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No standard guidelines exist. Use caution; clinical judgment is required as systemic protein turnover may be altered in severe hepatic or renal dysfunction.
## Contraindications
* **Hypersensitivity:** Known allergy to chymotrypsin, trypsin, or porcine-derived proteins.
* **Coagulopathy:** Patients with severe coagulation disorders (e.g., hemophilia) or those on high-dose therapeutic anticoagulation due to potential increased risk of bleeding from proteolytic fibrinolytic activity.
* **Severe Renal or Hepatic Insufficiency:** Use with extreme caution.
## Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, diarrhea, or abdominal bloating.
* **Allergic Reactions:** Urticaria, pruritus, or rare cases of anaphylaxis.
* **Systemic:** Potential for increased bleeding risk or hematuria in susceptible individuals.
## Key Drug Interactions
* **Anticoagulants/Antiplatelets:** May theoretically increase the risk of bleeding when combined with warfarin, heparin, aspirin, or NSAIDs.
* **Protease Inhibitors:** Potential for competitive or synergistic effects; clinical significance is unknown but warrants monitoring.
## Monitoring
* Monitor for signs of hypersensitivity reactions.
* Monitor for signs of abnormal bleeding (epistaxis, bruising, hematuria) if used concurrently with anticoagulants.
* Assess clinical response to reduction in inflammation or edema.
## Clinical Pearls
* **Absorption:** The enzyme must reach the small intestine intact to be absorbed. Do not crush, chew, or split enteric-coated tablets.
* **Evidence Base:** Clinical evidence supporting systemic enzyme therapy is generally considered weak or observational. It should not replace evidence-based anti-inflammatory therapy (e.g., NSAIDs, mechanical measures) unless specifically indicated by a healthcare provider.
* **Availability:** Availability varies significantly by country; always verify the exact USP activity content on the label, as formulations vary widely between manufacturers.
***
**Educational Disclaimer:** This information is for educational purposes only and does not constitute medical advice. Chymosin Forte formulations vary globally; always verify the exact manufacturer's labeling, local formulary guidelines, and patient-specific factors with a healthcare professional before prescribing or administering.
